表紙
市場調查報告書
商品編碼
1080075

全球注射劑市場:討論和預測,COVID-19 的潛在影響(2022-2026)

Global Injectables Market: Insights & Forecast with Potential Impact of COVID-19 (2022-2026)

出版日期: | 出版商: Koncept Analytics | 英文 100 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

2026 年全球注射劑市場規模將達到 8366 億美元,預計 2022 年至 2026 年的複合年增長率為 10.95%。老年人口增加、對便捷給藥的需求增加、生物製藥使用增加、醫療成本增加以及癌症發病率激增等因素可能會推動市場增長。

本報告提供對全球注射劑市場的研究和分析,包括 COVID-19 影響、區域分析、市場動態和競爭格局。

目錄

第一章市場概述

  • 簡介
  • 胃腸外給藥途徑
  • 腸胃外給藥途徑的類型
  • 注射劑處方
  • 有助於注射劑吸收的因素
  • 注射藥物的種類
  • 注射的好處

第 2 章 COVID-19 的影響

  • 加大注射劑研發管線投入
  • 血漿療法採用率迅速提高
  • 智能注射器的使用增加
  • 加快疫苗生產

第三章世界市場分析

  • 全球注塑市場(金額)
  • 全球注塑市場預測(金額)
  • 全球注塑市場:按類型
    • 全球創新者註入市場(金額)
    • 全球創新劑注入市場預測(金額)
    • 全球仿製藥注射劑市場(金額)
    • 全球仿製藥注射劑市場預測(金額)
    • 全球通用注射劑市場:按治療
    • 全球抗傳染病注射劑市場(金額)
    • 全球抗傳染病注射劑市場預測(金額)
    • 全球抗腫瘤/免疫調節注射劑市場(金額)
    • 全球抗腫瘤/免疫調節注射劑市場預測(金額)
    • 胃腸和代謝注射劑的全球市場價值
    • 全球胃腸及代謝注射劑市場價值預測
    • 全球血液相關注射劑市場(金額)
    • 全球血液相關注射劑市場預測(金額)
    • 全球中樞神經系統注射劑市場(金額)
    • 全球中樞神經系統注射液市場預測(金額)
    • 全球肌肉骨骼注射劑市場(金額)
    • 全球肌肉骨骼注射劑市場預測(金額)
  • 全球注塑市場:按地區
  • 全球通用注射劑市場:按地區

第四章區域市場分析

  • 北美
  • 歐洲
  • 中國
  • 印度
  • 其他領域

第五章市場動態

  • 生長促進劑
  • 主要趨勢和發展
  • 挑戰

第6章競爭態勢

  • 北美市場
    • 美國仿製藥注射劑市場份額:按主要公司分類
    • 美國仿製藥注射劑市場份額:按主要公司分類

第 7 章公司簡介

  • Novartis International AG
  • Pfizer Inc.
  • Fresenius SE & Co. KGaA
  • Baxter International Inc.
  • Shanghai Fosun Pharmaceutical Group Co. Ltd. (Gland Pharma Ltd.)
  • Hikma Pharmaceuticals PLC
目錄

The global injectables market is estimated to reach US$836.6 billion in 2026, progressing at a CAGR of 10.95%, over the period 2022-2026. Factors such as increasing geriatric population, upsurge in demand for convenient drug delivery, expanding use of biologics, rising healthcare expenditure and surging incidence of cancer cases would drive the growth of the market. However, the market growth would be challenged by stringent regulatory guidelines, emergence of alternative drug delivery methods and manufacturing complexity and high operational cost. A few notable trends may include accelerating prevalence of chronic diseases, growing adoption of self-injectable devices, upswing in drug shortages and advancements in technology.

Depending on the type, the global injectables market can be bifurcated into two main categories: innovator and generic. Further, generic injectables market can be split into Anti-Infectives (AI), Antineoplastics + Immunomodulators (AN+IM), Alimentary Tract + Metabolic (AT+Mb), Blood Related (BR), Central Nervous System (CNS), Musculoskeletal (Msk) and others, on the basis of therapy.

The fastest growing regional market is North America due to the improvements in healthcare infrastructure coupled with growing demand for injectables on account of high presence of a large number of patients with chronic diseases such as diabetes and arthritis which require frequent drug dosing and increasing research and development activities for the development of innovative injectables drugs.

Scope of the report:

  • The report provides a comprehensive analysis of the global injectables market segmented on the basis of type and region.
  • The major regional and country markets (North America, Europe, China, India and Rest of the World) have been analyzed.
  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
  • The competitive landscape of the market, along with the company profiles of leading players (Novartis International AG, Pfizer Inc., Fresenius SE & Co. KGaA, Baxter International Inc., Shanghai Fosun Pharmaceutical Group Co. Ltd. (Gland Pharma Ltd.) and Hikma Pharmaceuticals PLC) are also presented in detail.

Key Target Audience:

  • Injectable Drug Manufacturers & Distributers
  • Pharmaceutical, Biopharmaceutical & Biotechnological Companies
  • End Users (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers & Others)
  • Research and Development (R&D) Organizations
  • Government Bodies & Regulating Authorities

Table of Contents

1. Market Overview

  • 1.1 Introduction
  • 1.2 Parenteral Route of Drug Administration
  • 1.3 Types of Parenteral Routes of Administration
  • 1.4 Formulation of Injectable
  • 1.5 Factors Favoring the Absorption of Injectable Drugs
  • 1.6 Types of Injectable Drug Products
  • 1.7 Advantages of Injectable Drugs

2. Impact of COVID-19

  • 2.1 Growing Investments in the R&D Pipeline of Injectables
  • 2.2 Surging Adoption of Plasma Therapy
  • 2.3 Rising Usage of Smart Syringes
  • 2.4 Accelerating Vaccine Production

3. Global Market Analysis

  • 3.1 Global Injectables Market by Value
  • 3.2 Global Injectables Market Forecast by Value
  • 3.3 Global Injectables Market by Type
    • 3.3.1 Global Innovator Injectables Market by Value
    • 3.3.2 Global Innovator Injectables Market Forecast by Value
    • 3.3.3 Global Generic Injectables Market by Value
    • 3.3.4 Global Generic Injectables Market Forecast by Value
    • 3.3.5 Global Generic Injectables Market by Therapy
    • 3.3.6 Global Anti-Infective Injectables Market by Value
    • 3.3.7 Global Anti-Infective Injectables Market Forecast by Value
    • 3.3.8 Global Antineoplastic+ Immunomodulator Injectables Market by Value
    • 3.3.9 Global Antineoplastic+ Immunomodulator Injectables Market Forecast by Value
    • 3.3.10 Global Alimentary Tract + Metabolic Injectables Market by Value
    • 3.3.11 Global Alimentary Tract + Metabolic Injectables Market Forecast by Value
    • 3.3.12 Global Blood Related Injectables Market by Value
    • 3.3.13 Global Blood Related Injectables Market Forecast by Value
    • 3.3.14 Global Central Nervous System Injectables Market by Value
    • 3.3.15 Global Central Nervous System Injectables Market Forecast by Value
    • 3.3.16 Global Musculoskeletal Injectables Market by Value
    • 3.3.17 Global Musculoskeletal Injectables Market Forecast by Value
  • 3.4 Global Injectables Market by Region
  • 3.5 Global Generic Injectables Market by Region

4. Regional Market Analysis

  • 4.1 North America
    • 4.1.1 North America Injectables Market by Value
    • 4.1.2 North America Injectables Market Forecast by Value
    • 4.1.3 North America Generic Injectables Market Forecast by Value
    • 4.1.4 The U.S. Injectables Market by Value
    • 4.1.5 The U.S. Injectables Market Forecast by Value
    • 4.1.6 The U.S. Injectables Market by Type
    • 4.1.7 The U.S. Innovator Injectables Market Forecast by Value
    • 4.1.8 The U.S. Generic Injectables Market Forecast by Value
  • 4.2 Europe
    • 4.2.1 Europe Injectables Market by Value
    • 4.2.2 Europe Injectables Market Forecast by Value
    • 4.2.3 Europe Generic Injectables Market Forecast by Value
  • 4.3 China
    • 4.3.1 China Injectables Market by Value
    • 4.3.2 China Injectables Market Forecast by Value
    • 4.3.3 China Injectables Market by Type
    • 4.3.4 China Generic Injectables Market Forecast by Value
    • 4.3.5 China Innovator Injectables Market Forecast by Value
  • 4.4 India
    • 4.4.1 India Injectables Market by Value
    • 4.4.2 India Injectables Market Forecast by Value
    • 4.4.3 India Generic Injectables Market Forecast by Value
  • 4.5 RoW
    • 4.5.1 RoW Injectables Market by Value
    • 4.5.2 RoW Injectables Market Forecast by Value
    • 4.5.3 RoW Generic Injectables Market Forecast by Value

5. Market Dynamics

  • 5.1 Growth Drivers
    • 5.1.1 Increasing Geriatric Population
    • 5.1.2 Upsurge in Demand for Convenient Drug Delivery
    • 5.1.3 Expanding Use of Biologics
    • 5.1.4 Rising Healthcare Expenditure
    • 5.1.5 Surging Incidence of Cancer Cases
  • 5.2 Key Trends and Developments
    • 5.2.1 Accelerating Prevalence of Chronic Diseases
    • 5.2.2 Growing Adoption of Self-Injectable Devices
    • 5.2.3 Upswing in Drug Shortages
    • 5.2.4 Advancements in Technology
  • 5.3 Challenges
    • 5.3.1 Stringent Regulatory Guidelines
    • 5.3.2 Emergence of Alternative Drug Delivery Methods
    • 5.3.3 Manufacturing Complexity & High Operational Cost

6. Competitive Landscape

  • 6.1 North America Market
    • 6.1.1 The U.S. Generic Injectables Market Value Share by Key Players
    • 6.1.2 The U.S. Generic Injectables Market Volume Share by Key Players

7. Company Profiles

  • 7.1 Novartis International AG
    • 7.1.1 Business Overview
  • 7.2 Pfizer Inc.
    • 7.2.1 Business Overview
  • 7.3 Fresenius SE & Co. KGaA
    • 7.3.1 Business Overview
  • 7.4 Baxter International Inc.
    • 7.4.1 Business Overview
  • 7.5 Shanghai Fosun Pharmaceutical Group Co. Ltd. (Gland Pharma Ltd.)
    • 7.5.1 Business Overview
  • 7.6 Hikma Pharmaceuticals PLC
    • 7.6.1 Business Overview

List of Figures

  • Routes of Drug Administration
  • Types of Parenteral Routes of Administration
  • Factors Favoring the Absorption of Injectable Drugs
  • Types of Injectable Drug Products
  • Advantages of Injectable Drugs
  • Percentage of Drugs in R&D Pipeline Worldwide by Delivery Route (2020)
  • Global Plasma Therapy Market Forecast (2019-2024)
  • Global Smart Syringes Market (2018-2027)
  • Reported Vaccine Production Capacity (Q4 2020-2023)
  • Global Injectables Market by Value (2017-2021)
  • Global Injectables Market Forecast by Value (2022-2026)
  • Global Injectables Market by Type (2021)
  • Global Innovator Injectables Market by Value (2017-2021)
  • Global Innovator Injectables Market Forecast by Value (2022-2026)
  • Global Generic Injectables Market by Value (2017-2021)
  • Global Generic Injectables Market Forecast by Value (2022-2026)
  • Global Generic Injectables Market by Therapy (2021)
  • Global Anti-Infective Injectables Market by Value (2017-2021)
  • Global Anti-Infective Injectables Market Forecast by Value (2022-2026)
  • Global Antineoplastic+ Immunomodulator Injectables Market by Value (2017-2021)
  • Global Antineoplastic+ Immunomodulator Injectables Market Forecast by Value (2022-2026)
  • Global Alimentary Tract + Metabolic Injectables Market by Value (2017-2021)
  • Global Alimentary Tract + Metabolic Injectables Market Forecast by Value (2022-2026)
  • Global Blood Related Injectables Market by Value (2017-2021)
  • Global Blood Related Injectables Market Forecast by Value (2022-2026)
  • Global Central Nervous System Injectables Market by Value (2017-2021)
  • Global Central Nervous System Injectables Market Forecast by Value (2022-2026)
  • Global Musculoskeletal Injectables Market by Value (2017-2021)
  • Global Musculoskeletal Injectables Market Forecast by Value (2022-2026)
  • Global Injectables Market by Region (2021)
  • Global Generic Injectables Market by Region (2021)
  • North America Injectables Market by Value (2017-2021)
  • North America Injectables Market Forecast by Value (2022-2026)
  • North America Generic Injectables Market Forecast by Value (2021-2026)
  • The U.S. Injectables Market by Value (2017-2021)
  • The U.S. Injectables Market Forecast by Value (2022-2026)
  • The U.S. Injectables Market by Type (2021)
  • The U.S. Innovator Injectables Market Forecast by Value (2021-2026)
  • The U.S. Generic Injectables Market Forecast by Value (2021-2026)
  • Europe Injectables Market by Value (2017-2021)
  • Europe Injectables Market Forecast by Value (2022-2026)
  • Europe Generic Injectables Market Forecast by Value (2021-2026)
  • China Injectables Market by Value (2017-2021)
  • China Injectables Market Forecast by Value (2022-2026)
  • China Injectables Market by Type (2021)
  • China Generic Injectables Market Forecast by Value (2021-2026)
  • China Innovator Injectables Market Forecast by Value (2021-2026)
  • India Injectables Market by Value (2017-2021)
  • India Injectables Market Forecast by Value (2022-2026)
  • India Generic Injectables Market Forecast by Value (2021-2026)
  • RoW Injectables Market by Value (2017-2021)
  • RoW Injectables Market Forecast by Value (2022-2026)
  • RoW Generic Injectables Market Forecast by Value (2021-2026)
  • Global Population 65 Years and Above (2017-2021)
  • Global Spending on Injectables (2015 v/s 2020)
  • Global Biologics Market Revenue (2016-2022)
  • Global Healthcare Expenditure Per Capita (2017-2021)
  • Global Cancer Prevalence (2018-2023)
  • Global Diabetes Prevalence (2010-2045)
  • Distribution of the Global Injectable Drug Delivery Market by Device (2016 v/s 2025)
  • Percentage of New Drug Shortages in the U.S. (2017-2021)
  • The U.S. Generic Injectables Market Value Share by Key Players (2021)
  • The U.S. Generic Injectables Market Volume Share by Key Players (2021)